Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
about
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Study on Olaparib Plus Abirate ...... tion-resistant Prostate Cancer
@en
type
label
Study on Olaparib Plus Abirate ...... tion-resistant Prostate Cancer
@en
prefLabel
Study on Olaparib Plus Abirate ...... tion-resistant Prostate Cancer
@en
P17
P1476
A Randomised, Double-blind, Pl ...... Prostate Cancer (PROpel Study)
@en
P17
P3098
NCT03732820
P580
2018-10-31T00:00:00Z
P582
2021-04-13T00:00:00Z